[1]
Kumari, A., Rohatgi, R., Singh, A. and Kumar, R. 2020. Comparative study of intravenous hydralazine and labetalol in severe hypertensive disorders of pregnancy. International Journal of Reproduction, Contraception, Obstetrics and Gynecology. 9, 2 (Jan. 2020), 675–681. DOI:https://doi.org/10.18203/2320-1770.ijrcog20200357.